None of the 29 investors followed here reported a position in TNDM in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
| Member | Buys | Sells | Est. net | Last move |
|---|---|---|---|---|
| Gilbert Cisneros CA31 | 2 | +$16.0K | Bought Mar 3, 26 | |
| Josh Gottheimer NJ05 | 1 | 1 | +$0 | Bought Sep 22, 25 |
| Traded | Member | Owner | Type | Amount | Filed | Report |
|---|---|---|---|---|---|---|
| Mar 3, 26 | Gilbert Cisneros CA31 | Self | Buy | $1,001 - $15,000 | Apr 7, 26 (35d) | |
| Sep 22, 25 | Josh Gottheimer NJ05 | Joint | Buy | $1,001 - $15,000 | Oct 15, 25 (23d) | |
| Mar 19, 25 | Josh Gottheimer NJ05 | Joint | Sell | $1,001 - $15,000 | Apr 10, 25 (22d) | |
| Mar 4, 25 | Gilbert Cisneros CA31 | Self | Buy | $1,001 - $15,000 | Apr 7, 25 (34d) |
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -9.5 | 27.2 | -24.2 | 1.9 | -11.9 | -12.3 | 29.2 | 12.9 | -25.9 | -2.8 | −27.9% | ||
| 2025 | 2.9 | -40.3 | -13.5 | -12.1 | 17.6 | -6.0 | -16.4 | -19.7 | -3.0 | 15.3 | 50.1 | 4.6 | −39.0% |
| 2024 | -22.9 | 16.8 | 33.0 | 3.6 | 39.6 | -21.4 | -8.2 | 17.6 | -2.5 | -26.0 | -2.4 | 17.6 | +21.8% |
| 2023 | -9.4 | -12.0 | 13.2 | -2.5 | -34.3 | -5.6 | 42.3 | -21.6 | -24.1 | -16.7 | 17.0 | 46.1 | −34.2% |
| 2022 | -21.5 | -4.6 | 3.2 | -17.0 | -29.3 | -13.2 | 11.9 | -30.9 | 4.6 | 17.3 | -25.1 | 6.9 | −70.1% |
| 2021 | -3.2 | 3.6 | -8.1 | 4.1 | -7.1 | 14.1 | 11.6 | 3.2 | 6.4 | 14.2 | -5.7 | 17.1 | +57.3% |
| 2020 | 27.6 | -1.8 | -13.8 | 24.0 | 4.2 | 19.0 | 5.6 | 7.9 | 0.7 | -4.0 | -13.9 | 1.9 | +60.5% |
| 2019 | 14.5 | 50.8 | -3.2 | -3.3 | 11.6 | -5.9 | -1.7 | 14.2 | -18.6 | 4.4 | 12.1 | -13.6 | +57.0% |
| 2018 | 17.8 | 13.7 | 57.0 | 53.8 | 83.9 | 56.9 | 25.2 | 65.8 | -6.2 | -12.2 | -2.1 | 3.1 | +1508.9% |
| 2017 | 9.3 | 2.1 | -50.0 | -20.6 | -16.6 | 0.6 | -39.7 | 74.3 | -13.1 | -66.2 | 8.1 | -11.6 | −89.0% |
| 2016 | -23.7 | -0.8 | -2.6 | 27.8 | -41.2 | 15.1 | -12.1 | 7.5 | 7.4 | -21.0 | -59.5 | -12.2 | −81.8% |
| 2015 | -3.2 | -4.8 | 7.9 | 5.8 | -9.6 | -10.2 | 15.8 | -8.5 | -23.3 | 3.0 | 13.7 | 14.5 | −7.0% |
| 2014 | 0.3 | -0.4 | -14.2 | -20.5 | -7.6 | 0.1 | -23.2 | 13.3 | -5.2 | 19.7 | -12.0 | -10.1 | −50.7% |
| 2013 | 17.1 | +17.1% |
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 13, 2026 | Sheridan John FChief Executive Officer | — | 15.9K | — |
| Aug 13, 2026 | Carpenter RickChief Technology Officer | — | 2.5K | — |
| Aug 13, 2026 | Morrison Susan MOfficer | — | 2.8K | — |
| Aug 13, 2026 | Vosseller Leigh AChief Financial Officer | — | 4.1K | — |
| Aug 13, 2026 | Kyrillos Jean-ClaudeChief Operating Officer | — | 1K | — |
| Aug 13, 2026 | Gasser Elizabeth AnneOfficer | — | 3K | — |
| Aug 13, 2026 | Hansen Shannon MarieOfficer | — | 3K | — |
| Jul 14, 2026 | Kyrillos Jean-ClaudeChief Operating Officer | — | 3.6K | — |
| Jun 1, 2026 | Gasser Elizabeth AnneOfficer | Stock Gift at price 0.00 per share. | 7.2K | — |
| May 20, 2026 | Allen Dick PRetired | — | 8.8K | — |
| May 20, 2026 | Twomey Christopher JDirector | — | 8.8K | — |
| May 20, 2026 | Robertson Rebecca BDirector | — | 8.8K | — |
| May 20, 2026 | Howell-Koren Peyton R.Director | — | 8.8K | — |
| May 20, 2026 | Sodhi RajwantDirector | — | 8.8K | — |
| May 20, 2026 | Mcgroddy-Goetz KathleenDirector | — | 8.8K | — |
| May 20, 2026 | Cha MyoungilDirector | — | 8.8K | — |
| May 20, 2026 | Malagueira Joao Paulo FalcaoDirector | — | 8.8K | — |
| May 14, 2026 | Sheridan John FChief Executive Officer | Stock Award(Grant) at price 10.90 per share. | 1.3K | $14.56K |
| May 14, 2026 | Sheridan John FChief Executive Officer | — | 51.2K | — |
| May 14, 2026 | Carpenter RickChief Technology Officer | Stock Award(Grant) at price 10.90 per share. | 1.3K | $14.56K |
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
Buy / hold / sell counts